Corbett T. Berry, MD, PhD
Dermatology
Accepting new patients
Sees patients age 18 and up
Penn Dermatology Radnor
Penn Medicine Provider

About me

  • Assistant Professor of Clinical Dermatology

Education and training

  • Medical School: Drexel University College of Medicine
  • Residency: Lankenau Hospital
  • Residency: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating

510 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

November 2025
he was nice
November 2025
attentive
October 2025
he was easy to talk to.
October 2025
he is a very good doctor.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Berry is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Berry CT, Frazee CS, Herman PJ, Chen S, Chen A, Kuo Y, Ellebrecht CT. Current advancements in cellular immunotherapy for autoimmune disease , Semin Immunopathol, 47: 2025,7


Isabel Yoon, Leah Cohen MD, Corbett T. Berry, Shane M. Swink, Michele Khurana Extensive erosions and ulcerations in a newborn , Pediatric Dermatology: 2025


Benson T, Kovarik C, Berry C, Sobanko J, Rosenbach M. Treatment of periorbital xanthogranuloma with fractional carbon dioxide laser , JAAD Case Rep, 48: 2024,42-45


Lee CS, Chen S, Berry CT, Kelly AR, Herman PJ, Oh S, O'Connor RS, Payne AS, Ellebrecht CT. Fate induction in CD8 CAR T cells through asymmetric cell division , Nature: 2024


Yousefi M, Nakauka-Ddamba A, Berry CT, Li N, Schoenberger J, Bankler-Jukes D, Simeonov KP, Cedeno RJ, Yu Z, Lengner CJ. Calorie Restriction Governs Intestinal Epithelial Regeneration through Cell-Autonomous Regulation of mTORC1 in Reserve Stem Cells , Stem Cell Reports, 18: 2023,1048


Wang S, Berry CT, Treat JR, Jen M. Morphea after initiation of dupilumab in two pediatric atopic dermatitis patients , Pediatr Dermatol: 2023


Headen AC, Berry CT, Jen M, Rubin AI. Misdiagnosis of neutrophilic erythema of infancy as leukocytoclastic vasculitis: A potential diagnostic pitfall in an infantile inflammatory dermatosis , J Cutan Pathol: 2023


Choi YJ, Kim MS, Rhoades JH, Johnson NM, Berry CT, Root S, Chen Q, Tian Y, Fernandez RJ 3rd, Cramer Z, Adams-Tzivelekidis S, Li N, Johnson FB, Lengner CJ. Patient-Induced Pluripotent Stem Cell-Derived Hepatostellate Organoids Establish a Basis for Liver Pathologies in Telomeropathies , Cell Mol Gastroenterol Hepatol: 2023


Hedberg ML, Berry CT, Moshiri AS, Xiang Y, Yeh CJ, Attilasoy C, Capell BC, Seykora JT. Molecular Mechanisms of Cutaneous Squamous Cell Carcinoma , Int J Mol Sci, 23: 2022,3478


Berry CT, Berry KG, Abbott J, Jiang AJ, Ronner L, Mollanazar NK, Canada R, Pugliese DJ, Ogunleye TA. Resolution of acquired palmoplantar keratoderma and scurvy after treatment of multivitamin deficiencies , JAAD Case Rep, 22: 2022,27-30